These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34248952)

  • 21. Virulence alterations in staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibiotics.
    Chen J; Zhou H; Huang J; Zhang R; Rao X
    J Adv Res; 2021 Jul; 31():165-175. PubMed ID: 34194840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
    Engelhardt B
    Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk Between
    Horn CM; Kielian T
    Front Immunol; 2020; 11():621750. PubMed ID: 33613555
    [No Abstract]   [Full Text] [Related]  

  • 24. Nanoscale drug delivery systems and the blood-brain barrier.
    Alyautdin R; Khalin I; Nafeeza MI; Haron MH; Kuznetsov D
    Int J Nanomedicine; 2014; 9():795-811. PubMed ID: 24550672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adaptive immune system in diseases of the central nervous system.
    Wraith DC; Nicholson LB
    J Clin Invest; 2012 Apr; 122(4):1172-9. PubMed ID: 22466659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.
    Schilcher K; Horswill AR
    Microbiol Mol Biol Rev; 2020 Aug; 84(3):. PubMed ID: 32792334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central Nervous System-Infecting Pathogens Escherichia coli and Cryptococcus neoformans Exploit the Host Pdlim2 for Intracellular Traversal and Exocytosis in the Blood-Brain Barrier.
    Li Z; Bruno VM; Kim KS
    Infect Immun; 2021 Sep; 89(10):e0012821. PubMed ID: 34228504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The agr Inhibitors Solonamide B and Analogues Alter Immune Responses to Staphylococccus aureus but Do Not Exhibit Adverse Effects on Immune Cell Functions.
    Baldry M; Kitir B; Frøkiær H; Christensen SB; Taverne N; Meijerink M; Franzyk H; Olsen CA; Wells JM; Ingmer H
    PLoS One; 2016; 11(1):e0145618. PubMed ID: 26731096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of immune cell entry into the central nervous system.
    Engelhardt B
    Results Probl Cell Differ; 2006; 43():259-80. PubMed ID: 17068976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier drug discovery for central nervous system infections.
    Jong A; Huang SH
    Curr Drug Targets Infect Disord; 2005 Mar; 5(1):65-72. PubMed ID: 15777199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic diffusion to central nervous system].
    Cabrera-Maqueda JM; Fuentes Rumí L; Valero López G; Baidez Guerrero AE; García Molina E; Díaz Pérez J; García-Vázquez E
    Rev Esp Quimioter; 2018 Feb; 31(1):1-12. PubMed ID: 29390599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review on nanosystems as an effective approach against infections of
    Zhou K; Li C; Chen D; Pan Y; Tao Y; Qu W; Liu Z; Wang X; Xie S
    Int J Nanomedicine; 2018; 13():7333-7347. PubMed ID: 30519018
    [No Abstract]   [Full Text] [Related]  

  • 34. Innate immunity in the central nervous system.
    Ransohoff RM; Brown MA
    J Clin Invest; 2012 Apr; 122(4):1164-71. PubMed ID: 22466658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology-Based Diagnostics and Therapy for Pathogen-Related Infections in the CNS.
    Tamil Selvan S; Padmanabhan P; Zoltán Gulyás B
    ACS Chem Neurosci; 2020 Aug; 11(16):2371-2377. PubMed ID: 31726008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staphylococcus aureus Biofilm-Conditioned Medium Impairs Macrophage-Mediated Antibiofilm Immune Response by Upregulating KLF2 Expression.
    Alboslemy T; Yu B; Rogers T; Kim MH
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30692179
    [No Abstract]   [Full Text] [Related]  

  • 37. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities.
    Li H; Guan M; Zhang NN; Wang Y; Liang T; Wu H; Wang C; Sun T; Liu S
    Biomed Pharmacother; 2024 Aug; 177():117011. PubMed ID: 38917758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.
    Alajangi HK; Kaur M; Sharma A; Rana S; Thakur S; Chatterjee M; Singla N; Jaiswal PK; Singh G; Barnwal RP
    Mol Brain; 2022 Jun; 15(1):49. PubMed ID: 35650613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.